EQS — CMS: Siemens Healthineers AG: Release of a capital market information

EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052 Siemens Healthineers AG: Release of a capital market information 12.10.2026 / 18:00 CET/CEST Dissemination of a Post-admission Duties announcement transmitted by 1 EQS News — a service of 2 EQS Group. The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ Share buyback — 19^th Interim Reporting In the time period from and including 5 October 2026 until and including 11 October 2026, a number of 50,000 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 26 May 2026, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the sha